1. Home
  2. NXDT vs SGHT Comparison

NXDT vs SGHT Comparison

Compare NXDT & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NXDT

NexPoint Diversified Real Estate Trust

HOLD

Current Price

$5.47

Market Cap

259.1M

Sector

Finance

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$4.90

Market Cap

309.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXDT
SGHT
Founded
2012
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
259.1M
309.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NXDT
SGHT
Price
$5.47
$4.90
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$9.08
AVG Volume (30 Days)
157.8K
199.0K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
9.66%
N/A
EPS Growth
N/A
28.16
EPS
0.99
N/A
Revenue
N/A
$77,363,000.00
Revenue This Year
N/A
$11.67
Revenue Next Year
N/A
$10.39
P/E Ratio
$5.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$3.11
52 Week High
$5.95
$9.24

Technical Indicators

Market Signals
Indicator
NXDT
SGHT
Relative Strength Index (RSI) 55.41 43.14
Support Level $4.35 $4.76
Resistance Level $5.57 $5.25
Average True Range (ATR) 0.23 0.32
MACD -0.00 -0.08
Stochastic Oscillator 43.75 38.79

Price Performance

Historical Comparison
NXDT
SGHT

About NXDT NexPoint Diversified Real Estate Trust

NexPoint Diversified Real Estate Trust is an externally advised REIT focused on the acquisition, asset management, development, and disposition of opportunistic, value-add investments in real estate properties throughout the United States. The company has two reportable segments: The Diversified reportable segment is focused on investing in various commercial real estate property types and across the capital structure, including but not limited to, equity, mortgage, debt, mezzanine debt and preferred equity. The Hospitality segment is focused on operating and renovating its U.S. located hospitality assets that meet its investment objective and criteria. Its Portfolio includes investments in the single-family rental, self-storage, office, hospitality, life science and multifamily sectors.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: